Professor David Allsup - Mission Impossible? Can we cure chronic lymphocytic leukaemia?

Chronic lymphocytic leukaemia is the common blood cancer in the world. Around 5000 people per year are diagnosed with this condition in the UK. Many of those diagnosed will never develop symptoms, but around half will eventually need treatment. Until recently, this cancer was thought of as incurable but recent advances are challenging this concept.

About Professor David Allsup

Professor David Allsup is a Professor of Haematology with an Honorary NHS appointment with Hull University Teaching Hospitals, based in the Queens Centre for Oncology and Haematology at Castle Hill Hospital.

His research interests include platelet disorders, the biology of chronic lymphocytic leukaemia, novel therapeutic approaches for haematological malignancies and supportive care for persons with blood cancers. He has led multiple translational and clinical research programmes which have resulted in high-impact journal outputs.

He is the local haemophilia director and has additional clinical interests in inherited and acquired platelet disorders. He is also the local lead for chronic lymphocytic leukaemia (CLL), in which he has a long-standing research interest.

Find out more about David's research